 Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
| Descriptor ID |
D023241
|
| MeSH Number(s) |
E02.319.310.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in UAMS Profiles by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 2 | 3 | | 2017 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2015 | 3 | 2 | 5 | | 2014 | 3 | 3 | 6 | | 2013 | 1 | 2 | 3 | | 2012 | 0 | 3 | 3 | | 2011 | 4 | 4 | 8 | | 2010 | 2 | 4 | 6 | | 2009 | 3 | 2 | 5 | | 2008 | 4 | 1 | 5 | | 2007 | 0 | 4 | 4 | | 2006 | 2 | 1 | 3 | | 2005 | 6 | 2 | 8 | | 2004 | 2 | 2 | 4 | | 2003 | 3 | 1 | 4 | | 2002 | 5 | 1 | 6 | | 2001 | 3 | 0 | 3 | | 2000 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles over the past ten years.
-
Wang R, Haberlen SA, Palella FJ, Mugavero MJ, Margolick JB, Macatangay BJC, Martínez-Maza O, Jacobson LP, Abraham AG. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough? AIDS. 2018 11 13; 32(17):2547-2556.
-
Palella FJ, Li X, Gupta SK, Estrella MM, Phair JP, Margolick JB, Detels R, Kingsley L, Jacobson LP. Long-term kidney function, proteinuria, and associated risks among HIV-infected and uninfected men. AIDS. 2018 06 19; 32(10):1247-1256.
-
Pei Q, Han X, Zhang Y, Zhang W, Zhou DB. [Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb; 26(1):146-152.
-
Margolick JB, Bream JH, Martínez-Maza O, Lopez J, Li X, Phair JP, Koletar SL, Jacobson LP. Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study. . 2017 Apr 01; 74(4):407-417.
-
Slama L, Jacobson LP, Li X, Palella FJ, Margolick JB, Kingsley LA, Wiley DJ, Pialoux G, Dobs AS, Brown TT. Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men. . 2016 Jan 01; 71(1):57-64.
-
Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4.
-
Margolick JB, Apuzzo L, Singer J, Wong H, Lee T, Gallant JE, El-Helou P, Loutfy MR, Rachlis A, Fraser C, Kasper K, Tremblay C, Tossonian H, Conway B. A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection. PLoS One. 2015; 10(11):e0143259.
-
Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015 Jul 09; 126(2):160-6.
-
Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ, Bolan R, Rinaldo CR, Jacobson LP. Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. J Infect Dis. 2015 Oct 01; 212(7):1100-10.
-
Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martínez-Maza O, Bream JH. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015 Feb 20; 29(4):463-71.
-
Rainwater-Lovett K, Nkamba H, Mubiana-Mbewe M, Moore CB, Margolick J, Moss WJ. Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART. . 2014 Dec 15; 67(5):455-62.
-
Sacktor N, Miyahara S, Evans S, Schifitto G, Cohen B, Haughey N, Drewes JL, Graham D, Zink MC, Anderson C, Nath A, Pardo CA, McCarthy S, Hosey L, Clifford D. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol. 2014 Dec; 20(6):620-6.
-
Patil SP, Brown TT, Jacobson LP, Margolick JB, Laffan A, Johnson-Hill L, Godfrey R, Johnson J, Reynolds S, Schwartz AR, Smith PL. Sleep disordered breathing, fatigue, and sleepiness in HIV-infected and -uninfected men. PLoS One. 2014; 9(7):e99258.
-
Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, Moore CB, Margolick JB, Moss WJ. Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children. . 2014 Apr 15; 65(5):505-9.
-
Dugdale C, Zaller N, Bratberg J, Berk W, Flanigan T. Missed opportunities for HIV screening in pharmacies and retail clinics. J Manag Care Spec Pharm. 2014 Apr; 20(4):339-45.
-
Brigham EP, Patil SP, Jacobson LP, Margolick JB, Godfrey R, Johnson J, Johnson-Hill LM, Reynolds S, Schwartz AR, Smith PL, Brown TT. Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infection. Antivir Ther. 2014; 19(8):725-33.
-
Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, Kaplan LD, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Oriol A, Navarro JT, Dunleavy K, Little RF, Ratner L, Garcia O, Morgades M, Remick SC, Noy A, Sparano JA. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 Nov 07; 122(19):3251-62.
-
Gingo MR, Balasubramani GK, Kingsley L, Rinaldo CR, Alden CB, Detels R, Greenblatt RM, Hessol NA, Holman S, Huang L, Kleerup EC, Phair J, Sutton SH, Seaberg EC, Margolick JB, Wisniewski SR, Morris A. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS One. 2013; 8(3):e58812.
-
Muzaffar J, Usmani S, Abdallah AO, Anaissie E, Cottler-Fox M, Restrepo A. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):171-4.
-
Cohen HS, Cox C, Springer G, Hoffman HJ, Young MA, Margolick JB, Plankey MW. Prevalence of abnormalities in vestibular function and balance among HIV-seropositive and HIV-seronegative women and men. PLoS One. 2012; 7(5):e38419.
-
Schneider MF, Margolick JB, Jacobson LP, Reddy S, Martinez-Maza O, Muñoz A. Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy. . 2012 Apr 01; 59(4):389-92.
-
Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity. 2012 Mar 23; 36(3):491-501.
-
Salgado M, Rabi SA, O'Connell KA, Buckheit RW, Bailey JR, Chaudhry AA, Breaud AR, Marzinke MA, Clarke W, Margolick JB, Siliciano RF, Blankson JN. Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy. Retrovirology. 2011 Dec 05; 8:97.
-
Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses. 2012 Aug; 28(8):816-22.
-
Li X, Margolick JB, Jamieson BD, Rinaldo CR, Phair JP, Jacobson LP. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy. . 2011 Aug 15; 57(5):421-8.
-
Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, Margolick JB. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011 Sep; 66(9):1030-8.
-
Cilingiroglu M, Lather N, Youseff A, Helmy T. ST-elevation myocardial infarction due to a spontaneous thrombus in the left anterior descending artery in a young HIV-infected patient. Turk Kardiyol Dern Ars. 2011 Jun; 39(4):308-11.
-
Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN, Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM. Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav. 2011 Jun; 5(2):77-85.
-
Cook PF, Sousa KH, Matthews EE, Meek PM, Kwong J. Patterns of change in symptom clusters with HIV disease progression. J Pain Symptom Manage. 2011 Jul; 42(1):12-23.
|
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|